Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00664729 · ClinicalTrials.gov registry record · NA

Diet, Exercise, Metabolism, and Obesity in Older Women

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
112
Enrollment target

NCT00664729: Completed NA study, sponsored by Wake Forest University Health Sciences.

NCT00664729 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 112 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00664729, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target

Study Summary

Reductions in fat oxidation and resting metabolic rate (RMR) are associated with normal aging and are accelerated with menopause. As a result, postmenopausal women have an increased risk of abdominal obesity and ultimately the metabolic complications that lead to the insulin resistance syndrome and its associated risks (hyperlipidemia, type 2 diabetes, and coronary heart disease). Thus, there is a need to determine the most successful treatment to reduce visceral obesity in postmenopausal women. The purpose of this study is to determine if dietary-induced weight loss alone and/or weight loss combined with exercise at low and high- intensities differentially affect the reduction in visceral adipose tissue in postmenopausal women with abdominal obesity.

Interventions

  • BEHAVIORAL Caloric Restriction
  • BEHAVIORAL Caloric Restriction + Low-Intensity aerobic exercise
  • BEHAVIORAL Caloric Restriction plus High-intensity aerobic exercise

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2002-11
Est. Completion 2008-11
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT00664729 record still lists

NCT00664729 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 3 interventions - of which Caloric Restriction is the first listed.

NCT00664729 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00664729 about?

NCT00664729 is a clinical study titled "Diet, Exercise, Metabolism, and Obesity in Older Women". Reductions in fat oxidation and resting metabolic rate (RMR) are associated with normal aging and are accelerated with menopause. As a result, postmenopausal women have an increased risk of abdominal obesity and ultimately the metabolic complications that lead to the insulin resistance syndrome and ...

What is the current status of trial NCT00664729?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2002-11. Estimated completion is 2008-11.

What interventions are being tested in trial NCT00664729?

The interventions under investigation include: Caloric Restriction (BEHAVIORAL), Caloric Restriction + Low-Intensity aerobic exercise (BEHAVIORAL), Caloric Restriction plus High-intensity aerobic exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT00664729?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00664729's enrollment target sits among peer trials

112 813th of 2000 higher than 1,185 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04511013 · 112 participants · Phase 2

    A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • NCT04551560 · 112 participants · NA

    Stress and Congestive Heart Failure

  • NCT04872166 · 112 participants · Phase 1

    A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

  • NCT05024773 · 112 participants · Phase 3

    Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00664729, the US trial registry maintained by the National Library of Medicine. NCT00664729 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.